Antihypertensive Treatment Escalation and Maternal Outcomes During Expectant Management of Early-Onset Preeclampsia With Severe Features

The authors aimed to evaluate the relationship between the escalation of antihypertensive treatment and adverse maternal outcomes during the expectant management of early-onset preeclampsia with severe features. Their findings indicate that increasing the number of antihypertensive dose escalations is associated with a higher risk of maternal complications, suggesting that treatment escalation may reflect disease progression and could be a valuable factor in maternal risk assessment.